Litten Jason

Litten Jason is listed in filings as Chief Medical Officer at Genelux Corporation. This profile follows SEC Form 4 activity through Jan 7, 2026, including 1 public disclosure. Recent filings connect the profile to Genelux Corporation (GNLX). The current snapshot covers public activity from Jan 7, 2026. Reported amounts are shown as $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.